Financials
Financial year 2025
Worth noting
- A loss two years in a row.
Gross margin
€ 295,531
▲ 132% vs 2024
Profit
Caution€ -707,036
▼ 44% vs 2024
Debts
Low€ 206,731
▼ 80% vs 2024
Stellaris from Charleroi, company number BE0804341222, closed financial year 2025 with a result of € -707,036 after tax. For that financial year Stellaris recorded a gross margin of € 295,531 and equity of € 3.3 million. Compared with financial year 2024, the result moved from € -492,679 to € -707,036. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 12, 2026.
What happened at Stellaris?
What happened at Stellaris in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Vives Partners SRL stepped down as director. NBB
- SPARAXIS SA stepped down as director. NBB
- ELAIA Partners SRL stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 707,036. Source: NBB ↗
- Vives Partners SRL became a director. NBB
- SPARAXIS SA became a director. NBB
- ELAIA Partners SRL became a director. NBB
- FONDS DE CAPITAL A RISQUE 2020 stepped down as director. NBB
In short
From € 492,679 loss in 2024 to € 707,036 loss in 2025.
On average € 147,800 of value added per employee in 2025.
A new publication or filing at Stellaris? We notify you, reason included.
Follow StellarisNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind Stellaris is AET Management & Consultancy.
Directors
According to the 2025 annual accounts
Managing director · represented by Adil El Taghdouini
since 2023
Director · represented by Sandra Schoors
Also active at: NOVADIP BIOSCIENCES, TESSARES, AXINESIS +9 more
since 2025 · until 2031
Director · represented by Christine Franssen
Also active at: C.P. Bourg, A.M.B., Jean Goldschmidt International +228 more
since 2025 · until 2031
Director · represented by Florian Denis
Also active at: Rocket Finance, CONDOR HOLDCO, CONDOR BIDCO
since 2025 · until 2031
FONDS DE CAPITAL A RISQUE 2020
Director · represented by Elisabeth de Halleux
Also active at: MintT, LYS MEDICAL, APAXEN +5 more
since 2023 · until 2025
Establishments
Establishment units
Physical locations of this company
Rue Clément Ader 10
6041 Charleroi
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 31 companies are registered at this address.
Brussels South Charleroi BioPark Dev
€ 80,186 gross margin · 2025
ImmunXperts
€ 393,338 gross margin · 2024
LYS MEDICAL same network
€ -309,203 gross margin · 2025
SPECTRALYS BIOTECH
€ 143,689 gross margin · 2025
ProtonW.be
€ -7,643 gross margin · 2025
+26 more
Details
- Company number
- 0804.341.222
- VAT number
- BE 0804.341.222
- Registered office
- Rue Clément Ader 10, 6041 Charleroi
- Names & denominations
- Stellaris
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 27 July 2023
- Peppol
- Active · Active since 18 Dec 2025
- Contact
- adil@aetmc.be
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overige gespecialiseerde wetenschappelijke en technische activiteiten